95064 ⎘
Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems; Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
Compound having hydrocoumarin skeleton, liquid crystal composition, and liquid crystal display device
#302ANTIBACTERIAL AGENT AND ANTIBACTERIAL COMPOSITION
#303USE OF BENZO-FUSED HETEROCYLE SULFAMIDE DERIVATIVES FOR THE TREATMENT OF ANXIETY
#304COMPOSITIONS AND THERAPEUTIC METHODS INVOLVING ISOFLAVONES AND ANALOGUES THEREOF
#305Modulators of ATP-binding cassette transporters
#306Isoflavone metabolites
#307Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
#308Chroman derivatives
#3097,8-bicycloakyl-chroman derivatives
#310Synthesis of quaternary salt compounds
#311Synthesis of quaternary salt compounds
#312Use Of Rottlerin And Its Derivatives As Activators Of BK Channel For Therapy Of Hypertension And Related Disorders
#313Novel 8-Sulfonyl-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5HT6 Receptor
#314Process for isolation of desired isomers of nebivolol intermediates
#315DEUTERIUM-ENRICHED NEBIVOLOL
#316PROCESS FOR PREPARATION OF RACEMIC NEBIVOLOL
#317Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor
#318Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
#319Compositions and products containing S-equol, and methods for their making
#320Substituted Aminoalkyl- and Amidoalkyl-Benzopyran Derivatives
#321Nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
#322Therapeutic Morpholino-Substituted Compounds
#323Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors
#324FULVENE AND FULVALENE ANALOGS AND THEIR USE IN TREATING CANCERS
#325Selective Estrogen Receptor Modulators
#326Process for the Production of Nebivolol
#327DIACYLHYDRAZINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES IN MAMMALIAN SYSTEMS VIA AN ECDYSONE RECEPTOR COMPLEX
#328Therapeutic morpholino-substituted compounds
#329Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
#330CHROMANE AND CHROMENE DERIVATIVES AND USES THEREOF
#331Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
#332Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
#333Antagonists of the TRPV1 receptor and uses thereof
#334Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
#335ISOFLAVONE METABOLITES
#336Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
#337Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
#338Adamantyl acetamides as 11-β hydroxysteroid dehydrogenase inhibitors
#339Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof
#340Therapeutic Heterocyclic Compounds 507
#341Difluorosubstituted heterocyclic compounds and the use thereof in the form of components in liquid crystalline media
#342Modulators of ATP-binding cassette transporters
#343Thiourea derivatives and the pharmaceutical compositions containing the same
#344Chromane and chromene derivatives and uses thereof
#345Chromane Derivatives Method for Production and the Use Thereof
#346Process for the preparation of 2H-chromenes
#347Compositions and therapeutic methods involving isoflavones and analogues thereof
#348Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
#349Co-therapy for the treatment of epilepsy and related disorders
#350Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
#351Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
#352Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors
#353SOLID-STATE FORM OF CELECOXIB HAVING ENHANCED BIOAVAILABILITY
#354Melanin concentrating hormone antagonist
#355Preparation of flavonoid compounds
#356Process for preparation of racemic Nebivolol
#357Heterocyclic CETP inhibitors
#358Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
#359Arylsulfonyl chromans as 5-HTinhibitors
#360Benzopyran derivatives as potassium channel openers
#3616-Alkylamino-2-methyl-2′-(N-methyl substituted sulfonamido)methyl-2H-1-benzopyran derivative as anti-inflammatory inhibitor
#362Method for enantioselective hydrogenation of chromenes
#363Novel process for preparation of nebivolol intermediates
#3644-((4-(2-pyrrolidinylethoxy)phenyl)methyl)-3-(4-(trifluoromethyl)phenyl)-7-hydroxychromen-2one, pharmaceutically acceptable salts thereof and methods of use therewith
#365Hydroxylated nebivolol metabolites
#366Aromatic amides as potentiators of bioefficacy of anti-infective drugs
#367Quaternary salt CCR2 antagonists
#368Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
#369Chromane and chromene derivatives and uses thereof
#370Small molecule Bcl-xL/Bcl-2 binding inhibitors
#371Benzotropolone derivatives and modulation of inflammatory response
#372Substituted chroman derivatives
#373Preventives/remedies for urinary disturbance
#374Organic photoconductive material electrophotographic photoreceptor and image forming apparatus using the same
#375N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds
#376Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
#377Reaction product of resorcin and methyl ethyl ketone
#378Chroman derivatives and uses thereof
#379Selective estrogen receptor modulator
#380Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
#381Compositions and therapeutic methods involving isoflavones and analogues thereof
#382Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
#383Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia
#384Substituted aryl alkenoic acid heterocyclic amides
#385PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
#386Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors
#387Substituted chroman derivatives, medicaments and use in therapy
#388Chroman derivatives, medicaments and use in therapy
#389Cyclic and acyclic propenones for treating CNS disorders
#390Modulators of ATP-binding cassette transporters
#391Process for the preparation of nitroalkenes
#392Compounds for the treatment of inflammatory disorders
#393Preventives/remedies for urinary disturbance
#394Inhibitors of histone deacetylase
#395Hydrazone compound, electrophotographic photoreceptor comprising the hydrazone compound, and image forming apparatus equipped with the electrophotographic photoreceptor
#396Sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
#397SUBSTITUTED 4H-CHROMENES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF
#398Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
#399Hybrid 2-aminoterailin and aryl-substituted piperazine compounds and their use in altering CNS activity
#400Racemization method
#401Enantioselective separation method
#402Therapeutic chromone compounds
#403Photoracamization method
#404Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use
#405Agents and methods for the treatment of disorders associated with oxidative stress
#406Inhibitors of histone deacetylase
#407Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
#408Chalcone compound
#409Solid-state form of celecoxib having enhanced bioavailability
#410Selective estrogen receptor modulators
#411Selective estrogen receptor modulators
#412Chromene-containing compounds with anti-tubulin and vascular targeting activity
#413Isoflavone metabolites
#414Chroman derivatives
#4152,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
#416Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
#417Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
#418Bicyclic amides
#419Preventives/remedies for urinary disturbance
#420Process for producing aminobenzopyran compound
#421Therapeutic heterocyclic compounds
#422Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
#423Substituted 5-chroman-5-YL-ethylamine compounds and their use for the treatment of glaucoma
#424Substituted 4-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
#425Compounds that modulate PPAR activity and methods for their preparation
#426Benzopyran compounds useful for treating inflammatory conditions
#427Benzopyran compounds for use in the treatment and prevention of inflammation related conditions
#428Substituted cyclic compounds
#429Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
#430Compounds that modulate PPAR activity and methods for their preparation
#4317-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity
#432Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
#433Tartrate salts of (R)-3-N,N-dicyclo-butylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide
#434Therapeutic morpholino-substituted compounds
#435Perfluorinated amide salts and their uses as ionic conducting materials
#436(3R, 4R)-trans-3, 4-diarylchroman derivatives and a method for the prevention and/or treatment of estrogen dependent diseases
#437Chroman derivatives
#4387,8-bicycloalkyl-chroman derivatives
#439Treatment of mitochondrial diseases
#440Substituted cyclic compounds
#441Benzotropolone derivatives and modulation of inflammatory response
#442Substituted benzopyran derivatives for the treatment of inflammation
#443Heterocyclic retinoid compounds
#444Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of COX-2-mediated disorders
#445Therapeutic heterocyclic compounds
#446Methods for producing amino substituted chromanes and intermediates therefor
#447Antimicrobials from an epigenetics based fungal metabolite screening program
#448Antimicrobials from an epigenetics based fungal metabolite screening program
#449Antimicrobials from an epigenetics based fungal metabolite screening program